Exco InTouch is Named Microsoft Managed Partner within Life Sciences

Strengthened Partnership Facilitates Advancements in Patient Engagement Solutions

(25 June 2012) Exco InTouch, the leading provider of mobile patient engagement, data collection and communication solutions for the pharmaceutical and healthcare sectors, today announced that it has been named a Microsoft Managed Partner. Exco has been recognized by Microsoft’s Life Science team for the company’s unparalleled expertise in managing patients in regulatory and late phase clinical trials, as well as in the emerging mHealth space for marketed drugs.

Exco InTouch was selected based on a number of criteria, including the company’s established track record of providing unique solutions using cutting-edge technologies, in addition to revenue potential and growth. Exco InTouch is a global provider of regulatory compliant, simple and non-intrusive mobile patient communication solutions for clinical, late phase and mHealth studies. This enables sponsors and CROs to find and retain the right patients through engaging interactions and improved patient experience. The Managed Partner program will provide Exco InTouch with valuable resources to accelerate the adoption of its solutions in the life sciences market. 

Tim Davis of Exco InTouch said, “Exco InTouch is delighted to be included in the elite group of Microsoft Managed Partners. The early access we will receive to emerging Microsoft technologies, information, tools and support will enable us to develop the most advanced patient engagement solutions to date and our customers can look forward to experiencing these benefits as our partnership with Microsoft continues.”

“As the life sciences industry continues to adapt to increased regulatory standards and a higher volume of patients, new technology solutions have the potential to revolutionize the way we manage these processes, ” said Andrea McGonigle, managing director, Microsoft Life Sciences. “Exco InTouch is an example of a partner that can help companies deliver reliable data throughout their clinical and late phase studies in an accessible and user friendly way.”

For further information on the Exco InTouch range of solutions, please call +44 1279 709 040 or +1 877 327 5777 or visit www.excointouch.com.

-ENDS-

For further press information please contact: Michelle Valentine, The Scott Partnership, 1 Whiteside, Station Road, Holmes Chapel, Cheshire CW4 8AA Tel: +44 1477 539539 Fax: +44 1477 539540 e-mail: exco@scottpr.com

About Exco InTouch

Exco InTouch is the trusted global innovator of regulatory compliant, mobile patient engagement solutions for life sciences and healthcare companies involved in clinical, late phase and mHealth research. Using a combination of patented software and services delivered in a cloud environment, Exco’s solutions can be utilised on any electronic device. This safe, secure platform facilitates compliant patient communication across the clinical development process from early phase development right through to long term studies and mHealth. As a result, Exco can help its customers to improve clinical outcomes by putting the patient at the heart of a study and enhancing the overall patient experience.

Exco’s solutions are currently being used by hundreds of thousands of patients in over seventy countries, delivered in the local language and are fully compliant with HIPAA regulations, FDA CFR 21 Part 11 and all electronic communication privacy directives.